DrugsControl Media Services

News Detail

Moderna, Generation Bio Launch Non-Viral Genetic Medicines Collaboration (24-03-2023)

Cambridge, 23 March 2023: Moderna will apply Generation Bio’s proprietary stealth cell-targeted lipid nanoparticle (ctLNP) delivery system to discover and develop non-viral genetic medicines for immune system and liver disorders, through a collaboration that could generate ......
View Details

Source : Genetic Engineering and Biotechnology News
moderna generation bio immune system health news genetic medicines DNA technology ctLNPs

Related News